{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:04:25Z","timestamp":1791043465144,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.idc.2012.08.011","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T17:03:31Z","timestamp":1350493411000},"page":"995-1010","source":"Crossref","is-referenced-by-count":17,"title":["Diagnosis and Treatment of Acute Hepatitis C Virus Infection"],"prefix":"10.1016","volume":"26","author":[{"given":"Christoph","family":"Boesecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen Kurt","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idc.2012.08.011_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"55","author":"European Association for the Study of the Liver","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2012.08.011_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1746.2003.03270.x","article-title":"Surveillance for newly acquired hepatitis C in Australia","volume":"19","author":"Robotin","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.idc.2012.08.011_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/00365540500525161","article-title":"Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004","volume":"38","author":"Wu","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib5","doi-asserted-by":"crossref","first-page":"18880","DOI":"10.2807\/ese.13.21.18880-en","article-title":"Surveillance and epidemiology of hepatitis B and C in Europe\u2014a review","volume":"13","author":"Rantala","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.idc.2012.08.011_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2012.08.011_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2893.2000.00179.x","article-title":"Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group","volume":"7","author":"Mele","year":"2000","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.idc.2012.08.011_bib8","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.idc.2012.08.011_bib9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.idc.2012.08.011_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1258\/095646207779949880","article-title":"High hepatitis C virus prevalence and incidence among Canadian intravenous drug users","volume":"18","author":"Roy","year":"2007","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.idc.2012.08.011_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2009.01.006","article-title":"Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience","volume":"102","author":"Roy","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"Grebely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2012.08.011_bib13","doi-asserted-by":"crossref","first-page":"i47","DOI":"10.1136\/gutjnl-2012-302062","article-title":"HIV and viral hepatitis co-infections: advances and challenges","volume":"61","author":"Lacombe","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.idc.2012.08.011_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib15","first-page":"1","article-title":"Surveillance for acute viral hepatitis\u2014United States, 2007","volume":"58","author":"Daniels","year":"2009","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.idc.2012.08.011_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/600058","article-title":"Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals: experience from 2 large German networks on the study of acute HCV infection","volume":"49","author":"Vogel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2012.08.011_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-0028-1109149","article-title":"The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection","volume":"47","author":"Deterding","year":"2009","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.idc.2012.08.011_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/sti.79.2.160","article-title":"Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples","volume":"79","author":"Marincovich","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.idc.2012.08.011_bib19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1572-0241.2004.04150.x","article-title":"Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study","volume":"99","author":"Vandelli","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.idc.2012.08.011_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/OLQ.0b013e3181ec9de5","article-title":"Sexual transmission of hepatitis C virus in human immunodeficiency virus-negative men who have sex with men: a series of case reports","volume":"38","author":"van de Laar","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2010.06.008","article-title":"Acute hepatitis C infection with evidence of heterosexual transmission","volume":"49","author":"Nguyen","year":"2010","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.idc.2012.08.011_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s10461-008-9403-3","article-title":"Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles","volume":"13","author":"Carey","year":"2009","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2012.08.011_bib23","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2105\/AJPH.2006.098582","article-title":"Determinants of recent HIV infection among Seattle-area men who have sex with men","volume":"99","author":"Thiede","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.idc.2012.08.011_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.qai.0000191281.77954.27","article-title":"Clinical presentation and course of acute hepatitis C infection in HIV-infected patients","volume":"41","author":"Luetkemeyer","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2008.11.049","article-title":"Rare birds in North America: acute hepatitis C cohorts","volume":"136","author":"Cox","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.idc.2012.08.011_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/sti.2007.027334","article-title":"Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002\u20132006: is this an outbreak?","volume":"84","author":"Giraudon","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"47","key":"10.1016\/j.idc.2012.08.011_bib27","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19042-en","article-title":"Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England","volume":"13","author":"Ruf","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.idc.2012.08.011_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2807\/esm.10.05.00535-en","article-title":"Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001\u20132004","volume":"10","author":"Gambotti","year":"2005","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.idc.2012.08.011_bib29","first-page":"515","article-title":"Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases","volume":"23","author":"Morin","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.idc.2012.08.011_bib30","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32832e5631","article-title":"Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic","volume":"23","author":"Urbanus","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2012.08.011_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/431486","article-title":"Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study","volume":"41","author":"Rauch","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib32","unstructured":"Gallotta G, Gali L, De Bona A, et\u00a0al. Acute hepatitis C virus in HIV co-infected men who have sex with men: Milan, 1996\u20132007. Presented at the 4th International HIV and Hepatitis Co-infection. Madrid, June 19\u201321, 2008."},{"key":"10.1016\/j.idc.2012.08.011_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/596770","article-title":"Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C","volume":"48","author":"Matthews","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/341976","article-title":"Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus","volume":"35","author":"Sherman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/592171","article-title":"Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe","volume":"198","author":"Soriano","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2012.08.011_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/cid\/ciq200","article-title":"Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian Trial in Acute Hepatitis C","volume":"52","author":"Matthews","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib37","first-page":"43","article-title":"Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management","volume":"69","author":"Arends","year":"2011","journal-title":"Neth J Med"},{"issue":"8","key":"10.1016\/j.idc.2012.08.011_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1293.2011.00912.x","article-title":"Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype","volume":"12","author":"Neukam","year":"2011","journal-title":"HIV Med"},{"issue":"39","key":"10.1016\/j.idc.2012.08.011_bib39","doi-asserted-by":"crossref","first-page":"19673","DOI":"10.2807\/ese.15.39.19673-en","article-title":"Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009","volume":"15","author":"Bottieau","year":"2010","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.idc.2012.08.011_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365548.2010.524660","article-title":"Incidence and characteristics of sexually transmitted acute hepatitis C virus infection among HIV-positive men who have sex with men in Copenhagen, Denmark during four years (2006-2009): a retrospective cohort study","volume":"43","author":"Barfod","year":"2011","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2012.08.011_bib41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(09)70264-6","article-title":"Acute hepatitis C and HIV coinfection","volume":"9","author":"Dionne-Odom","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib42","unstructured":"Remis RA. Study to Characterize the Epidemiology of Hepatitis C Infection in Canada. 2002. Final Report. Public Health Agency of Canada. Available at: http:\/\/www.phac-aspc.gc.ca\/hepc\/pubs\/hepc2002\/index-eng.php. Accessed May 20, 2012."},{"key":"10.1016\/j.idc.2012.08.011_bib43","unstructured":"Lebanese Republic, Ministry of Public Health. UNGASS Country Progress Report\u00a0Lebanon March 2010. Available at: http:\/\/www.unaids.org\/en\/dataanalysis\/monitoringcountryprogress\/2010progressreportssubmittedbycountries\/lebanon_2010_country_progress_report_en.pdf. Accessed May 20, 2012."},{"key":"10.1016\/j.idc.2012.08.011_bib44","unstructured":"Boesecke C, Stellbrink HJ, Mauss S, et\u00a0al. Does Baseline HCV Genotype Have an Impact upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals? Presented at the 18th Conference on Retroviruses and Opportunistic Infections. Boston, February 27-March 2, 2011."},{"issue":"3","key":"10.1016\/j.idc.2012.08.011_bib45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/JCM.06014-11","article-title":"Recent hepatitis C virus infection in HIV-positive patients in Taiwan: incissdence and risk factors","volume":"50","author":"Sun","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib46","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0929-6646(08)60106-0","article-title":"Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users","volume":"107","author":"Lee","year":"2008","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.idc.2012.08.011_bib47","unstructured":"Larsen C, Alric L, Auperin I, et\u00a0al. Acute hepatitis C in HIV-infected men who have sex with men in France in 2006 and 2007. Presented at the 58th Annual Meeting of the American Association for the Study of the Liver. Boston, November 2\u20136, 2007."},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib48","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/j.1365-2893.2010.01392.x","article-title":"Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort","volume":"18","author":"Clausen","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"issue":"8","key":"10.1016\/j.idc.2012.08.011_bib49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/QAD.0b013e3283471cce","article-title":"The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007","volume":"25","author":"van der Helm","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2012.08.011_bib50","unstructured":"Fierer D, Fishman S, Uriel A, et\u00a0al. Characterization of an outbreak of acute HCV infection in HIV-infected men in New York city. Presented at the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, February 8\u201311, 2009."},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/0956462052932629","article-title":"Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection","volume":"16","author":"Hung","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"3","key":"10.1016\/j.idc.2012.08.011_bib52","doi-asserted-by":"crossref","first-page":"e17781","DOI":"10.1371\/journal.pone.0017781","article-title":"Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany\u2013a case-control study","volume":"6","author":"Schmidt","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2012.08.011_bib53","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.idc.2012.08.011_bib54","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1478-3231.2010.02305.x","article-title":"Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany","volume":"30","author":"Vogel","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.idc.2012.08.011_bib55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/605561","article-title":"Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria","volume":"24","author":"McGovern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","article-title":"Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference","volume":"25","author":"The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2362.2007.01753.x","article-title":"Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia","volume":"37","author":"Kubitschke","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2012.08.011_bib59","doi-asserted-by":"crossref","first-page":"P200","DOI":"10.1186\/1758-2652-13-S4-P200","article-title":"Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR","volume":"13","author":"Stellbrink","year":"2010","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"17","key":"10.1016\/j.idc.2012.08.011_bib60","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"High incidence rate of HCV reinfection after treatment of acute HCV infection in HIV-infected MSM in Amsterdam","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2012.08.011_bib61","unstructured":"Ingiliz P, Krznaric I, Hoffmann C, et\u00a0al. Prior HCV Infection Does Not Protect from Sexually Transmitted HCV Reinfection in HIV+ MSM. Presented at the 19th Conference on Retroviruses and Opportunistic Infections. Seattle, March 5\u20138, 2012."},{"key":"10.1016\/j.idc.2012.08.011_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jhep.2000.8169","article-title":"Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study","volume":"32","author":"Wiese","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib64","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.23850","article-title":"Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection","volume":"52","author":"Grebely","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2012.08.011_bib65","unstructured":"Jones L, Uriel A, Kaplan D, et\u00a0al. Natural history and treatment outcome of acute hepatitis C with and without HIV co-infection in a North American cohort. Peesented at the AASLD 2008 Meeting. San Francisco, California. October 31-November 1, 2008."},{"issue":"6","key":"10.1016\/j.idc.2012.08.011_bib66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"Thomson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.idc.2012.08.011_bib67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2012.08.011_bib68","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2893.2009.01256.x","article-title":"Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection","volume":"17","author":"Grebely","year":"2009","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.idc.2012.08.011_bib69","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib70","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1086\/504327","article-title":"Acute hepatitis C virus infection in incarcerated injection drug users","volume":"42","author":"McGovern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib71","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2009.02.203","article-title":"New insights into the immunopathogenesis of chronic hepatitis C","volume":"82","author":"Diepolder","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.idc.2012.08.011_bib73","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00018-008-8270-4","article-title":"Immunological determinants of the outcomes from primary hepatitis C infection","volume":"66","author":"Post","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.idc.2012.08.011_bib74","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.idc.2012.08.011_bib75","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.idc.2012.08.011_bib76","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.idc.2012.08.011_bib77","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1128\/JVI.73.4.2938-2946.1999","article-title":"Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy","volume":"73","author":"Ray","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.idc.2012.08.011_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.idc.2012.08.011_bib79","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jhep.2012.01.021","article-title":"Lack of TGF-\u03b2 production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection","volume":"56","author":"Harfouch","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib80","doi-asserted-by":"crossref","first-page":"e1002045","DOI":"10.1371\/journal.ppat.1002045","article-title":"Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells","volume":"7","author":"Schlaphoff","year":"2011","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.20100388","article-title":"Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence","volume":"209","author":"Schulze Zur Wiesch","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"5685","key":"10.1016\/j.idc.2012.08.011_bib82","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.idc.2012.08.011_bib83","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/infdis\/jis210","article-title":"Interferon \u03b1-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1","volume":"205","author":"Stegmann","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.idc.2012.08.011_bib85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.qai.0000174930.64145.a9","article-title":"Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin","volume":"40","author":"Gilleece","year":"2005","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.idc.2012.08.011_bib86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2893.2006.00795.x","article-title":"Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?","volume":"14","author":"Harris","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.idc.2012.08.011_bib87","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.idc.2012.08.011_bib88","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.idc.2012.08.011_bib89","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2011.09.039","article-title":"Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection","volume":"142","author":"Beinhardt","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.idc.2012.08.011_bib91","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A\u00a0polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.idc.2012.08.011_bib92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2893.2011.01497.x","article-title":"IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection","volume":"19","author":"Rao","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"issue":"2","key":"10.1016\/j.idc.2012.08.011_bib93","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2012.03.020","article-title":"Immediate versus delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis","volume":"57","author":"Deuffic-Burban","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib94","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/590430","article-title":"Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study","volume":"198","author":"Fierer","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib95","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cid\/cir854","article-title":"Liver fibrosis progression after acute HCV infection (AHC) in HIV-positive individuals","volume":"54","author":"Vogel","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib96","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2012.08.011_bib97","doi-asserted-by":"crossref","unstructured":"Deterding K, Gruner NH, Buggisch P, et\u00a0al. Early versus delayed treatment of acute hepatitis C: the German HEP-NET Acute HCV-III study - a randomized controlled trial. Presented at the 47th Annual Meeting of the European Association for the Study of the Liver (EASL 2012). Barcelona, Spain, April 18\u201322, 2012.","DOI":"10.1055\/s-0029-1241337"},{"issue":"3","key":"10.1016\/j.idc.2012.08.011_bib98","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MEG.0b013e32832c7b2e","article-title":"Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany","volume":"22","author":"Dintsios","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0b013e3283422e09","article-title":"Acute hepatitis C infection in HIV-positive patients","volume":"24","author":"Vogel","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idc.2012.08.011_bib100","unstructured":"Vogel M, Page E, Matthews G, et\u00a0al. Use of week 4 HCV RNA after acute HCV infection to predict chronic HCV infection. Presented at the 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, California, February 16\u201319, 2010."},{"issue":"1","key":"10.1016\/j.idc.2012.08.011_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2009.09.019","article-title":"Effective treatment of injecting drug users with recently acquired hepatitis C virus infection","volume":"138","author":"Dore","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.idc.2012.08.011_bib102","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2012.08.011_bib103","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.20196","article-title":"Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial","volume":"39","author":"Nomura","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2012.08.011_bib104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santantonio","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.idc.2012.08.011_bib105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.idc.2012.08.011_bib106","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/135965350601100817","article-title":"Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals","volume":"11","author":"Vogel","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.idc.2012.08.011_bib107","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/QAD.0b013e328330ed24","article-title":"Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus","volume":"23","author":"Schnuriger","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2012.08.011_bib108","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/01.aids.0000226956.02719.fd","article-title":"Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients","volume":"20","author":"Dominguez","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2012.08.011_bib109","unstructured":"Kruk A. Efficacy of acute HCV treatment with peg-interferon alfa-2b and ribavirin in HIV-infected patients. Presented at the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, July 24\u201327, 2005."},{"key":"10.1016\/j.idc.2012.08.011_bib110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.aids.0000200541.40633.56","article-title":"Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy","volume":"20","author":"Serpaggi","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.idc.2012.08.011_bib111","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hep.23959","article-title":"Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study","volume":"52","author":"Piroth","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.idc.2012.08.011_bib112","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/aid.2007.0011","article-title":"Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial","volume":"23","author":"Nunez","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.idc.2012.08.011_bib113","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/2047-783X-15-3-102","article-title":"The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals","volume":"15","author":"Vogel","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.idc.2012.08.011_bib114","doi-asserted-by":"crossref","unstructured":"Matthews G, Grebely J, Hellard M, et\u00a0al. Differences in early virological decline in individuals treated within the Australian Trial in Acute HCV suggest a potential benefit for the use of ribavirin. Presented at the 45th Annual Meeting\u00a0of the European Association for the Study of the Liver (EASL). Vienna, Austria, April 14\u201318, 2010.","DOI":"10.1016\/S0168-8278(10)60062-1"},{"issue":"13","key":"10.1016\/j.idc.2012.08.011_bib115","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/QAD.0b013e3283553719","article-title":"Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV\/HIV co-infection","volume":"26","author":"Grebely","year":"2012","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib116","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/infdis\/jiq098","article-title":"Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C","volume":"203","author":"Nattermann","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib117","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrgastro.2011.32","article-title":"Treatment of acute HCV infection","volume":"8","author":"Grebely","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.idc.2012.08.011_bib118","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2893.2006.00802.x","article-title":"A\u00a0short course of pegylated interferon-alpha in acute HCV hepatitis","volume":"14","author":"Calleri","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.idc.2012.08.011_bib119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3851\/IMP1501","article-title":"Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort","volume":"15","author":"Vogel","year":"2010","journal-title":"Antivir Ther"},{"issue":"10","key":"10.1016\/j.idc.2012.08.011_bib120","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0b013e3283480144","article-title":"Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.idc.2012.08.011_bib121","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/hep.24152","article-title":"Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals?","volume":"53","author":"Matthews","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcv.2011.08.020","article-title":"Successful treatment of acute hepatitis C virus in HIV positive patients using the European AIDS Treatment Network guidelines for treatment duration","volume":"52","author":"Dorward","year":"2011","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.idc.2012.08.011_bib123","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jmv.21133","article-title":"Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods","volume":"80","author":"Carlsson","year":"2008","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.idc.2012.08.011_bib124","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep.21348","article-title":"Treatment duration in acute hepatitis C: the issue is not solved yet","volume":"44","author":"Wedemeyer","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.idc.2012.08.011_bib125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/COH.0b013e32834732cd","article-title":"Treatment of acute hepatitis C infection in HIV-infected patients","volume":"6","author":"Boesecke","year":"2011","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552012000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552012000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T07:38:16Z","timestamp":1687765096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552012000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0891552012000980"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2012.08.011","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}